EUVIMEDEUVIMED entdecken
Crossref

4152 PREOPERATIVE GLP-1 RECEPTOR AGONIST (GLP-1 RA) USE PREDICTS POSTOPERATIVE GLP-1 RA USE, BUT NOT GREATER PERCENT TOTAL WEIGHT LOSS (%TWL), 1-YEAR AFTER METABOLIC/BARIATRIC SURGERY (BMS)

Surgery for Obesity and Related Diseases · 2026-04 · 22 (4) · S64

DOI: 10.1016/j.soard.2026.02.213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery for Obesity and Related Diseases, 2026-04.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). 4152 PREOPERATIVE GLP-1 RECEPTOR AGONIST (GLP-1 RA) USE PREDICTS POSTOPERATIVE GLP-1 RA USE, BUT NOT GREATER PERCENT TOTAL WEIGHT LOSS (%TWL), 1-YEAR AFTER METABOLIC/BARIATRIC SURGERY (BMS). Surgery for Obesity and Related Diseases, 22(4), S64. https://doi.org/10.1016/j.soard.2026.02.213

Vancouver

4152 PREOPERATIVE GLP-1 RECEPTOR AGONIST (GLP-1 RA) USE PREDICTS POSTOPERATIVE GLP-1 RA USE, BUT NOT GREATER PERCENT TOTAL WEIGHT LOSS (%TWL), 1-YEAR AFTER METABOLIC/BARIATRIC SURGERY (BMS). Surgery for Obesity and Related Diseases. 2026;22(4):S64. doi:10.1016/j.soard.2026.02.213

BibTeX
@article{euvimed2026,
  title = {4152 PREOPERATIVE GLP-1 RECEPTOR AGONIST (GLP-1 RA) USE PREDICTS POSTOPERATIVE GLP-1 RA USE, BUT NOT GREATER PERCENT TOTAL WEIGHT LOSS (%TWL), 1-YEAR AFTER METABOLIC/BARIATRIC SURGERY (BMS)},
  journal = {Surgery for Obesity and Related Diseases},
  year = {2026},
  volume = {22},
  number = {4},
  pages = {S64},
  doi = {10.1016/j.soard.2026.02.213}
}
Kostenlos starten →